Scilex Holding Co (SCLX)
0.9054
+0.04
(+4.07%)
USD |
NASDAQ |
May 17, 16:00
0.938
+0.03
(+3.60%)
Pre-Market: 20:00
Scilex Cash from Operations (Quarterly): 9.391M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.391M |
| December 31, 2023 | -5.39M |
| September 30, 2023 | 5.90M |
| June 30, 2023 | -13.47M |
| March 31, 2023 | -7.744M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.725M |
| September 30, 2022 | 2.533M |
| June 30, 2022 | -12.34M |
| March 31, 2022 | -10.73M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.47M
Minimum
Jun 2023
9.391M
Maximum
Mar 2024
-3.619M
Average
-5.39M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Sorrento Therapeutics Inc | -55.66M |
| Adial Pharmaceuticals Inc | -1.223M |
| Precision BioSciences Inc | -18.98M |
| Humacyte Inc | -27.35M |
| Perspective Therapeutics Inc | 13.85M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.15M |
| Cash from Financing (Quarterly) | -11.20M |
| Free Cash Flow | -4.052M |
| Free Cash Flow Per Share (Quarterly) | 0.0902 |
| Free Cash Flow to Equity (Quarterly) | 25.46M |
| Free Cash Flow to Firm (Quarterly) | 9.772M |
| Free Cash Flow Yield | -3.74% |